103 related articles for article (PubMed ID: 20159909)
41. Do Toll-like receptors contribute to the pathogenesis of lupus?
Youinou P
J Rheumatol; 2007 Aug; 34(8):1641-2. PubMed ID: 17696280
[No Abstract] [Full Text] [Related]
42. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
43. Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis.
Lech M; Skuginna V; Kulkarni OP; Gong J; Wei T; Stark RW; Garlanda C; Mantovani A; Anders HJ
J Pathol; 2010 Apr; 220(5):596-607. PubMed ID: 20112371
[TBL] [Abstract][Full Text] [Related]
44. The altered expression of inflammation-related molecules and secretion of IL-6 and IL-8 by HUVEC from newborns with maternal inactive systemic lupus erythematosus is modified by estrogens.
Rodriguez E; Guevara J; Paez A; Zapata E; Collados MT; Fortoul TI; Lopez-Marure R; Masso F; Montaño LF
Lupus; 2008 Dec; 17(12):1086-95. PubMed ID: 19029276
[TBL] [Abstract][Full Text] [Related]
45. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus.
Llorente L; Richaud-Patin Y; Wijdenes J; Alcocer-Varela J; Maillot MC; Durand-Gasselin I; Fourrier BM; Galanaud P; Emilie D
Eur Cytokine Netw; 1993; 4(6):421-7. PubMed ID: 8186374
[TBL] [Abstract][Full Text] [Related]
46. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
47. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans.
Isnardi I; Ng YS; Srdanovic I; Motaghedi R; Rudchenko S; von Bernuth H; Zhang SY; Puel A; Jouanguy E; Picard C; Garty BZ; Camcioglu Y; Doffinger R; Kumararatne D; Davies G; Gallin JI; Haraguchi S; Day NK; Casanova JL; Meffre E
Immunity; 2008 Nov; 29(5):746-57. PubMed ID: 19006693
[TBL] [Abstract][Full Text] [Related]
48. IVIg attenuates TLR-9 activation in B cells from SLE patients.
Kessel A; Peri R; Haj T; Snir A; Slobodin G; Sabo E; Rosner I; Shoenfeld Y; Toubi E
J Clin Immunol; 2011 Feb; 31(1):30-8. PubMed ID: 20922561
[TBL] [Abstract][Full Text] [Related]
49. The Chaperone UNC93B1 Regulates Toll-like Receptor Stability Independently of Endosomal TLR Transport.
Pelka K; Bertheloot D; Reimer E; Phulphagar K; Schmidt SV; Christ A; Stahl R; Watson N; Miyake K; Hacohen N; Haas A; Brinkmann MM; Marshak-Rothstein A; Meissner F; Latz E
Immunity; 2018 May; 48(5):911-922.e7. PubMed ID: 29768176
[TBL] [Abstract][Full Text] [Related]
50. Long-term improvement of lipid profile in patients with refractory systemic lupus erythematosus treated with B-cell depletion therapy: a retrospective observational study.
Pego-Reigosa JM; Lu TY; Fontanillo MF; del Campo-Pérez V; Rahman A; Isenberg DA
Rheumatology (Oxford); 2010 Apr; 49(4):691-6. PubMed ID: 20047982
[TBL] [Abstract][Full Text] [Related]
51. Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus.
Ma K; Li J; Fang Y; Lu L
Int J Mol Sci; 2015 Jun; 16(6):13084-105. PubMed ID: 26068236
[TBL] [Abstract][Full Text] [Related]
52. Human CD72 splicing isoform responsible for resistance to systemic lupus erythematosus regulates serum immunoglobulin level and is localized in endoplasmic reticulum.
Hitomi Y; Adachi T; Tsuchiya N; Honda Z; Tokunaga K; Tsubata T
BMC Immunol; 2012 Dec; 13():72. PubMed ID: 23268649
[TBL] [Abstract][Full Text] [Related]
53. TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA.
Chockalingam A; Brooks JC; Cameron JL; Blum LK; Leifer CA
Immunol Cell Biol; 2009; 87(3):209-17. PubMed ID: 19079358
[TBL] [Abstract][Full Text] [Related]
54. Unc93b Induces Apoptotic Cell Death and Is Cleaved by Host and Enteroviral Proteases.
Harris KG; Coyne CB
PLoS One; 2015; 10(10):e0141383. PubMed ID: 26509685
[TBL] [Abstract][Full Text] [Related]
55. Cell-specific TLR9 trafficking in primary APCs of transgenic TLR9-GFP mice.
Avalos AM; Kirak O; Oelkers JM; Pils MC; Kim YM; Ottinger M; Jaenisch R; Ploegh HL; Brinkmann MM
J Immunol; 2013 Jan; 190(2):695-702. PubMed ID: 23241879
[TBL] [Abstract][Full Text] [Related]
56. B cells twist and shout.
Davidson A; Diamond B
Immunol Cell Biol; 2009 Oct; 87(7):512-3. PubMed ID: 19736562
[No Abstract] [Full Text] [Related]
57. B cell signature during inactive systemic lupus is heterogeneous: toward a biological dissection of lupus.
Garaud JC; Schickel JN; Blaison G; Knapp AM; Dembele D; Ruer-Laventie J; Korganow AS; Martin T; Soulas-Sprauel P; Pasquali JL
PLoS One; 2011; 6(8):e23900. PubMed ID: 21886837
[TBL] [Abstract][Full Text] [Related]
58. Assembly and secretion of antibodies during B cell development.
Maggioni C; Carelli S; Cabibbo A; Fagioli C; Fra AM; Sitia R
Bratisl Lek Listy; 1998; 99(8-9):419-25. PubMed ID: 9810765
[No Abstract] [Full Text] [Related]
59. Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase.
Ewald SE; Engel A; Lee J; Wang M; Bogyo M; Barton GM
J Exp Med; 2011 Apr; 208(4):643-51. PubMed ID: 21402738
[TBL] [Abstract][Full Text] [Related]
60. Genetic variants in UNC93B1 predispose to childhood-onset systemic lupus erythematosus.
Al-Azab M; Idiiatullina E; Liu Z; Lin M; Hrovat-Schaale K; Xian H; Zhu J; Yang M; Lu B; Zhao Z; Liu Y; Chang J; Li X; Guo C; Liu Y; Wu Q; Chen J; Lan C; Zeng P; Cui J; Gao X; Zhou W; Zhang Y; Zhang Y; Masters SL
Nat Immunol; 2024 Jun; 25(6):969-980. PubMed ID: 38831104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
